Assessment of long-term psychosocial outcomes in N-methyl-D-aspartate receptor encephalitis – the SAPIENCE study protocol
Background N-methyl-D-aspartate-receptor (NMDAR) encephalitis is a rare neurological autoimmune disease with severe neuropsychiatric symptoms during the acute phase. Despite good functional neurological recovery, most patients continue to experience cognitive, psychiatric, psychological, and social...
Saved in:
| Published in | BMC neurology Vol. 24; no. 1; pp. 322 - 8 |
|---|---|
| Main Authors | , , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
London
BioMed Central
06.09.2024
BioMed Central Ltd BMC |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1471-2377 1471-2377 |
| DOI | 10.1186/s12883-024-03842-6 |
Cover
| Abstract | Background
N-methyl-D-aspartate-receptor (NMDAR) encephalitis is a rare neurological autoimmune disease with severe neuropsychiatric symptoms during the acute phase. Despite good functional neurological recovery, most patients continue to experience cognitive, psychiatric, psychological, and social impairments years after the acute phase. However, the precise nature and evolving patterns over time of these long-term consequences remain unclear, and their implications for the well-being and quality of life of predominantly young patients have yet to be thoroughly examined.
Methods
SAPIENCE is a European multi-center (
n
= 3) prospective observational cohort study studying the long-term cognitive, psychiatric, psychological, and social outcome in patients with NMDAR encephalitis. The study consists of three interconnected levels. Level 1 comprises a qualitative interview and focus groups with patients and their caregivers. Level 2 consists of a condensed form of the interview, standardized questionnaires, and a detailed neuropsychological examination of patients. Level 3 involves an online survey that will be open to patients world-wide and explores patient-reported outcomes (PROMs), and patient-reported experiences (PREMs) in association with clinical and cognitive outcomes. Levels 1 to 3 will progressively contribute developing of structured interviews, survey questions, and treatment guidelines by informing one another.
Discussion
SAPIENCE is an in-depth study of the long-term effects of NMDAR encephalitis and bridges the gap between standardized assessments and individual patient experiences, intending to improve patient care and to increase awareness of the psychosocial long-term consequences of the disease. Through collaboration of experts in clinical neurology and social and health psychology across Europe, SAPIENCE aims to create online assessment tools and formulate guidelines for patient-centered post-acute care that will help enhance the quality of life for patients and caregivers. |
|---|---|
| AbstractList | Background
N-methyl-D-aspartate-receptor (NMDAR) encephalitis is a rare neurological autoimmune disease with severe neuropsychiatric symptoms during the acute phase. Despite good functional neurological recovery, most patients continue to experience cognitive, psychiatric, psychological, and social impairments years after the acute phase. However, the precise nature and evolving patterns over time of these long-term consequences remain unclear, and their implications for the well-being and quality of life of predominantly young patients have yet to be thoroughly examined.
Methods
SAPIENCE is a European multi-center (
n
= 3) prospective observational cohort study studying the long-term cognitive, psychiatric, psychological, and social outcome in patients with NMDAR encephalitis. The study consists of three interconnected levels. Level 1 comprises a qualitative interview and focus groups with patients and their caregivers. Level 2 consists of a condensed form of the interview, standardized questionnaires, and a detailed neuropsychological examination of patients. Level 3 involves an online survey that will be open to patients world-wide and explores patient-reported outcomes (PROMs), and patient-reported experiences (PREMs) in association with clinical and cognitive outcomes. Levels 1 to 3 will progressively contribute developing of structured interviews, survey questions, and treatment guidelines by informing one another.
Discussion
SAPIENCE is an in-depth study of the long-term effects of NMDAR encephalitis and bridges the gap between standardized assessments and individual patient experiences, intending to improve patient care and to increase awareness of the psychosocial long-term consequences of the disease. Through collaboration of experts in clinical neurology and social and health psychology across Europe, SAPIENCE aims to create online assessment tools and formulate guidelines for patient-centered post-acute care that will help enhance the quality of life for patients and caregivers. Abstract Background N-methyl-D-aspartate-receptor (NMDAR) encephalitis is a rare neurological autoimmune disease with severe neuropsychiatric symptoms during the acute phase. Despite good functional neurological recovery, most patients continue to experience cognitive, psychiatric, psychological, and social impairments years after the acute phase. However, the precise nature and evolving patterns over time of these long-term consequences remain unclear, and their implications for the well-being and quality of life of predominantly young patients have yet to be thoroughly examined. Methods SAPIENCE is a European multi-center ( n = 3) prospective observational cohort study studying the long-term cognitive, psychiatric, psychological, and social outcome in patients with NMDAR encephalitis. The study consists of three interconnected levels. Level 1 comprises a qualitative interview and focus groups with patients and their caregivers. Level 2 consists of a condensed form of the interview, standardized questionnaires, and a detailed neuropsychological examination of patients. Level 3 involves an online survey that will be open to patients world-wide and explores patient-reported outcomes (PROMs), and patient-reported experiences (PREMs) in association with clinical and cognitive outcomes. Levels 1 to 3 will progressively contribute developing of structured interviews, survey questions, and treatment guidelines by informing one another. Discussion SAPIENCE is an in-depth study of the long-term effects of NMDAR encephalitis and bridges the gap between standardized assessments and individual patient experiences, intending to improve patient care and to increase awareness of the psychosocial long-term consequences of the disease. Through collaboration of experts in clinical neurology and social and health psychology across Europe, SAPIENCE aims to create online assessment tools and formulate guidelines for patient-centered post-acute care that will help enhance the quality of life for patients and caregivers. BackgroundN-methyl-D-aspartate-receptor (NMDAR) encephalitis is a rare neurological autoimmune disease with severe neuropsychiatric symptoms during the acute phase. Despite good functional neurological recovery, most patients continue to experience cognitive, psychiatric, psychological, and social impairments years after the acute phase. However, the precise nature and evolving patterns over time of these long-term consequences remain unclear, and their implications for the well-being and quality of life of predominantly young patients have yet to be thoroughly examined.MethodsSAPIENCE is a European multi-center (n = 3) prospective observational cohort study studying the long-term cognitive, psychiatric, psychological, and social outcome in patients with NMDAR encephalitis. The study consists of three interconnected levels. Level 1 comprises a qualitative interview and focus groups with patients and their caregivers. Level 2 consists of a condensed form of the interview, standardized questionnaires, and a detailed neuropsychological examination of patients. Level 3 involves an online survey that will be open to patients world-wide and explores patient-reported outcomes (PROMs), and patient-reported experiences (PREMs) in association with clinical and cognitive outcomes. Levels 1 to 3 will progressively contribute developing of structured interviews, survey questions, and treatment guidelines by informing one another.DiscussionSAPIENCE is an in-depth study of the long-term effects of NMDAR encephalitis and bridges the gap between standardized assessments and individual patient experiences, intending to improve patient care and to increase awareness of the psychosocial long-term consequences of the disease. Through collaboration of experts in clinical neurology and social and health psychology across Europe, SAPIENCE aims to create online assessment tools and formulate guidelines for patient-centered post-acute care that will help enhance the quality of life for patients and caregivers. N-methyl-D-aspartate-receptor (NMDAR) encephalitis is a rare neurological autoimmune disease with severe neuropsychiatric symptoms during the acute phase. Despite good functional neurological recovery, most patients continue to experience cognitive, psychiatric, psychological, and social impairments years after the acute phase. However, the precise nature and evolving patterns over time of these long-term consequences remain unclear, and their implications for the well-being and quality of life of predominantly young patients have yet to be thoroughly examined. SAPIENCE is a European multi-center (n = 3) prospective observational cohort study studying the long-term cognitive, psychiatric, psychological, and social outcome in patients with NMDAR encephalitis. The study consists of three interconnected levels. Level 1 comprises a qualitative interview and focus groups with patients and their caregivers. Level 2 consists of a condensed form of the interview, standardized questionnaires, and a detailed neuropsychological examination of patients. Level 3 involves an online survey that will be open to patients world-wide and explores patient-reported outcomes (PROMs), and patient-reported experiences (PREMs) in association with clinical and cognitive outcomes. Levels 1 to 3 will progressively contribute developing of structured interviews, survey questions, and treatment guidelines by informing one another. SAPIENCE is an in-depth study of the long-term effects of NMDAR encephalitis and bridges the gap between standardized assessments and individual patient experiences, intending to improve patient care and to increase awareness of the psychosocial long-term consequences of the disease. Through collaboration of experts in clinical neurology and social and health psychology across Europe, SAPIENCE aims to create online assessment tools and formulate guidelines for patient-centered post-acute care that will help enhance the quality of life for patients and caregivers. Background N-methyl-D-aspartate-receptor (NMDAR) encephalitis is a rare neurological autoimmune disease with severe neuropsychiatric symptoms during the acute phase. Despite good functional neurological recovery, most patients continue to experience cognitive, psychiatric, psychological, and social impairments years after the acute phase. However, the precise nature and evolving patterns over time of these long-term consequences remain unclear, and their implications for the well-being and quality of life of predominantly young patients have yet to be thoroughly examined. Methods SAPIENCE is a European multi-center (n = 3) prospective observational cohort study studying the long-term cognitive, psychiatric, psychological, and social outcome in patients with NMDAR encephalitis. The study consists of three interconnected levels. Level 1 comprises a qualitative interview and focus groups with patients and their caregivers. Level 2 consists of a condensed form of the interview, standardized questionnaires, and a detailed neuropsychological examination of patients. Level 3 involves an online survey that will be open to patients world-wide and explores patient-reported outcomes (PROMs), and patient-reported experiences (PREMs) in association with clinical and cognitive outcomes. Levels 1 to 3 will progressively contribute developing of structured interviews, survey questions, and treatment guidelines by informing one another. Discussion SAPIENCE is an in-depth study of the long-term effects of NMDAR encephalitis and bridges the gap between standardized assessments and individual patient experiences, intending to improve patient care and to increase awareness of the psychosocial long-term consequences of the disease. Through collaboration of experts in clinical neurology and social and health psychology across Europe, SAPIENCE aims to create online assessment tools and formulate guidelines for patient-centered post-acute care that will help enhance the quality of life for patients and caregivers. Keywords: NMDA receptor encephalitis, Health-related quality of life, Patient-reported outcome measures, Patient-reported experience measures, Cognitive outcomes, Post-acute interventions, Social & caregiver burden N-methyl-D-aspartate-receptor (NMDAR) encephalitis is a rare neurological autoimmune disease with severe neuropsychiatric symptoms during the acute phase. Despite good functional neurological recovery, most patients continue to experience cognitive, psychiatric, psychological, and social impairments years after the acute phase. However, the precise nature and evolving patterns over time of these long-term consequences remain unclear, and their implications for the well-being and quality of life of predominantly young patients have yet to be thoroughly examined.BACKGROUNDN-methyl-D-aspartate-receptor (NMDAR) encephalitis is a rare neurological autoimmune disease with severe neuropsychiatric symptoms during the acute phase. Despite good functional neurological recovery, most patients continue to experience cognitive, psychiatric, psychological, and social impairments years after the acute phase. However, the precise nature and evolving patterns over time of these long-term consequences remain unclear, and their implications for the well-being and quality of life of predominantly young patients have yet to be thoroughly examined.SAPIENCE is a European multi-center (n = 3) prospective observational cohort study studying the long-term cognitive, psychiatric, psychological, and social outcome in patients with NMDAR encephalitis. The study consists of three interconnected levels. Level 1 comprises a qualitative interview and focus groups with patients and their caregivers. Level 2 consists of a condensed form of the interview, standardized questionnaires, and a detailed neuropsychological examination of patients. Level 3 involves an online survey that will be open to patients world-wide and explores patient-reported outcomes (PROMs), and patient-reported experiences (PREMs) in association with clinical and cognitive outcomes. Levels 1 to 3 will progressively contribute developing of structured interviews, survey questions, and treatment guidelines by informing one another.METHODSSAPIENCE is a European multi-center (n = 3) prospective observational cohort study studying the long-term cognitive, psychiatric, psychological, and social outcome in patients with NMDAR encephalitis. The study consists of three interconnected levels. Level 1 comprises a qualitative interview and focus groups with patients and their caregivers. Level 2 consists of a condensed form of the interview, standardized questionnaires, and a detailed neuropsychological examination of patients. Level 3 involves an online survey that will be open to patients world-wide and explores patient-reported outcomes (PROMs), and patient-reported experiences (PREMs) in association with clinical and cognitive outcomes. Levels 1 to 3 will progressively contribute developing of structured interviews, survey questions, and treatment guidelines by informing one another.SAPIENCE is an in-depth study of the long-term effects of NMDAR encephalitis and bridges the gap between standardized assessments and individual patient experiences, intending to improve patient care and to increase awareness of the psychosocial long-term consequences of the disease. Through collaboration of experts in clinical neurology and social and health psychology across Europe, SAPIENCE aims to create online assessment tools and formulate guidelines for patient-centered post-acute care that will help enhance the quality of life for patients and caregivers.DISCUSSIONSAPIENCE is an in-depth study of the long-term effects of NMDAR encephalitis and bridges the gap between standardized assessments and individual patient experiences, intending to improve patient care and to increase awareness of the psychosocial long-term consequences of the disease. Through collaboration of experts in clinical neurology and social and health psychology across Europe, SAPIENCE aims to create online assessment tools and formulate guidelines for patient-centered post-acute care that will help enhance the quality of life for patients and caregivers. N-methyl-D-aspartate-receptor (NMDAR) encephalitis is a rare neurological autoimmune disease with severe neuropsychiatric symptoms during the acute phase. Despite good functional neurological recovery, most patients continue to experience cognitive, psychiatric, psychological, and social impairments years after the acute phase. However, the precise nature and evolving patterns over time of these long-term consequences remain unclear, and their implications for the well-being and quality of life of predominantly young patients have yet to be thoroughly examined. SAPIENCE is a European multi-center (n = 3) prospective observational cohort study studying the long-term cognitive, psychiatric, psychological, and social outcome in patients with NMDAR encephalitis. The study consists of three interconnected levels. Level 1 comprises a qualitative interview and focus groups with patients and their caregivers. Level 2 consists of a condensed form of the interview, standardized questionnaires, and a detailed neuropsychological examination of patients. Level 3 involves an online survey that will be open to patients world-wide and explores patient-reported outcomes (PROMs), and patient-reported experiences (PREMs) in association with clinical and cognitive outcomes. Levels 1 to 3 will progressively contribute developing of structured interviews, survey questions, and treatment guidelines by informing one another. SAPIENCE is an in-depth study of the long-term effects of NMDAR encephalitis and bridges the gap between standardized assessments and individual patient experiences, intending to improve patient care and to increase awareness of the psychosocial long-term consequences of the disease. Through collaboration of experts in clinical neurology and social and health psychology across Europe, SAPIENCE aims to create online assessment tools and formulate guidelines for patient-centered post-acute care that will help enhance the quality of life for patients and caregivers. |
| ArticleNumber | 322 |
| Audience | Academic |
| Author | Heine, Josephine Duda-Sikula, Marta Mendes, Álvaro Howard, Fuchsia Honnorat, Jérôme Benaiteau, Marie Buttard, Chloé Patricio, Víctor Finke, Carsten Kurpas, Donata Boeken, Ole Jonas Dalmau, Josep Picard, Géraldine Easton, Ava |
| Author_xml | – sequence: 1 givenname: Ole Jonas surname: Boeken fullname: Boeken, Ole Jonas organization: Department of Neurology, Charité – Universitätsmedizin Berlin – sequence: 2 givenname: Josephine surname: Heine fullname: Heine, Josephine organization: Department of Neurology, Charité – Universitätsmedizin Berlin – sequence: 3 givenname: Marta surname: Duda-Sikula fullname: Duda-Sikula, Marta organization: Department of Family and Pediatric Nursing, Faculty of Health Sciences, WrocławDepartment of Family Medicine, Wroclaw Medical University – sequence: 4 givenname: Víctor surname: Patricio fullname: Patricio, Víctor organization: Fundacio de Clinic per a la Recerca Clinic Barcelona - Biomédica (FCRB) - Institut de Investigacions – sequence: 5 givenname: Géraldine surname: Picard fullname: Picard, Géraldine organization: French reference center on paraneoplastic neurological diseases and autoimmune encephalitis, UMR MELIS Inserm, Université Claude Bernard Lyon1 – sequence: 6 givenname: Chloé surname: Buttard fullname: Buttard, Chloé organization: French reference center on paraneoplastic neurological diseases and autoimmune encephalitis, UMR MELIS Inserm, Université Claude Bernard Lyon1 – sequence: 7 givenname: Marie surname: Benaiteau fullname: Benaiteau, Marie organization: French reference center on paraneoplastic neurological diseases and autoimmune encephalitis, UMR MELIS Inserm, Université Claude Bernard Lyon1 – sequence: 8 givenname: Álvaro surname: Mendes fullname: Mendes, Álvaro organization: Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Portugal – sequence: 9 givenname: Fuchsia surname: Howard fullname: Howard, Fuchsia organization: Faculty of Applied Sciences, The University of British Columbia – sequence: 10 givenname: Ava surname: Easton fullname: Easton, Ava organization: Encephalitis International, Department of Clinical Infection, Microbiology and Immunology, University of Liverpool – sequence: 11 givenname: Donata surname: Kurpas fullname: Kurpas, Donata organization: Department of Family and Pediatric Nursing, Faculty of Health Sciences, WrocławDepartment of Family Medicine, Wroclaw Medical University – sequence: 12 givenname: Jérôme surname: Honnorat fullname: Honnorat, Jérôme organization: French reference center on paraneoplastic neurological diseases and autoimmune encephalitis, UMR MELIS Inserm, Université Claude Bernard Lyon1 – sequence: 13 givenname: Josep surname: Dalmau fullname: Dalmau, Josep organization: Fundacio de Clinic per a la Recerca Clinic Barcelona - Biomédica (FCRB) - Institut de Investigacions – sequence: 14 givenname: Carsten surname: Finke fullname: Finke, Carsten email: carsten.finke@charite.de organization: Department of Neurology, Charité – Universitätsmedizin Berlin |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39242986$$D View this record in MEDLINE/PubMed https://univ-lyon1.hal.science/hal-04986624$$DView record in HAL |
| BookMark | eNp9ks1u1DAUhSNURH_gBVggS2xgkeK_OM5yNAx0pFFBAtaWx7mZ8SiJB9upNGLDO_CGPAlOU1paoSqLOFffOb735pxmR73rIcteEnxOiBTvAqFSshxTnmMmOc3Fk-yE8JLklJXl0T_n4-w0hB3GpJScPMuOWUU5raQ4yX7MQoAQOugjcg1qXb_JI_gO7cPBbF1wxuoWuSEa10FAtkeXeQdxe2jz97kOe-2jjoA8GNhH5xH06bDVrY02oN8_f6G4BfRl9nm5uJwvUIhDfUB776Izrn2ePW10G-DFzfss-_Zh8XV-ka8-fVzOZ6vcFFLEnBgKWvJSNlVDRVmz9KEFFAUTGtfClAzXqYCZKWWNZbMG3lSg11WVxgSG2Vm2nHxrp3dq722n_UE5bdV1wfmNSmNY04JiJRESajC1XPO0VEloWa8rSXBRyEYWyevt5JVmvGd1MVupsYZ52qug_Iok9s3EpoG_DxCi6mww0La6BzcExUj6IVUhqrHF1w_QnRt8n7YyUpSXlRDsjtro1KvtGxe9NqOpmkksGeOE0USd_4dKTw2dNSlCjU31e4JXN5cP6w7q27H-piQBdAKMdyF4aG4RgtUYRTVFUaVO1XUU1SiSD0TGpqxY16d2bPu4lE3SkO7pN-DvtvGI6g-Ipe_4 |
| CitedBy_id | crossref_primary_10_1212_NXI_0000000000200343 |
| Cites_doi | 10.1016/S0513-5117(08)79015-X 10.1016/S1474-4422(15)00401-9 10.1212/NXI.0000000000200168 10.1016/0165-1781(89)90047-4 10.1111/1475-6773.13187 10.1017/S1355617716000679 10.1093/geronb/57.1.P19 10.1016/j.brainres.2019.146549 10.2147/IJGM.S397429 10.3758/s13428-023-02134-0 10.1016/S2215-0366(17)30330-9 10.1037/t00742-000 10.3233/NRE-141176 10.1016/S1474-4422(12)70310-1 10.1007/s10508-012-0016-6 10.1016/S1474-4422(22)00299-X 10.1016/j.jclinepi.2010.04.011 10.1007/s11136-011-9903-x 10.1002/ana.23932 10.1016/j.jneuroim.2017.08.010 10.1136/jnnp-2017-316822 10.1212/WNL.0000000000009987 10.1007/s00415-019-09230-2 10.1212/NXI.0000000000001064 10.1016/j.yebeh.2020.107088 10.3389/fimmu.2021.796965 10.1177/160940691000900106 10.1016/j.chc.2018.07.005 10.1007/s11065-017-9349-1 10.1002/ana.25754 10.3389/fneur.2023.1170961 10.1016/j.yebeh.2020.107066 10.1016/j.biopsych.2015.02.024 10.1111/j.1600-0447.1983.tb09716.x 10.1016/S1474-4422(08)70224-2 10.1111/medu.14380 10.1212/NXI.0000000000200189 10.1016/j.neuroscience.2015.05.037 10.1136/jnnp-2011-300411 10.3390/brainsci11111387 10.1093/bjaed/mkw060 10.31234/osf.io/8hmxu 10.1007/s00415-016-8083-6 10.1016/S1474-4422(19)30244-3 10.1007/s00415-016-8277-y 10.1016/S1474-4422(10)70253-2 10.1002/ana.26241 10.1002/ana.25131 10.1212/WNL.0000000000005605 10.1212/WNL.0000000000006783 10.1212/NXI.0000000000000514 10.1007/s00415-021-10828-8 10.1177/2042533313479197 10.1001/archneur.1989.00520460115022 |
| ContentType | Journal Article |
| Copyright | The Author(s) 2024 2024. The Author(s). COPYRIGHT 2024 BioMed Central Ltd. 2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. Distributed under a Creative Commons Attribution 4.0 International License |
| Copyright_xml | – notice: The Author(s) 2024 – notice: 2024. The Author(s). – notice: COPYRIGHT 2024 BioMed Central Ltd. – notice: 2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: Distributed under a Creative Commons Attribution 4.0 International License |
| DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7TK 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 1XC VOOES DOA |
| DOI | 10.1186/s12883-024-03842-6 |
| DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Neurosciences Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials - QC ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database Proquest Central Premium ProQuest One Academic (New) ProQuest - Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic Hyper Article en Ligne (HAL) Hyper Article en Ligne (HAL) (Open Access) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Neurosciences Abstracts ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | Publicly Available Content Database MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 5 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1471-2377 |
| EndPage | 8 |
| ExternalDocumentID | oai_doaj_org_article_37168edecd8b40388127db9810558f85 oai_HAL_hal_04986624v1 A808334132 39242986 10_1186_s12883_024_03842_6 |
| Genre | Multicenter Study Journal Article Observational Study |
| GeographicLocations | Europe Germany |
| GeographicLocations_xml | – name: Europe – name: Germany |
| GrantInformation_xml | – fundername: Charité - Universitätsmedizin Berlin (3093) |
| GroupedDBID | --- 0R~ 23N 2WC 53G 5VS 6J9 6PF 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAWTL ABDBF ABIVO ABUWG ACGFO ACGFS ACIHN ACPRK ACUHS ADBBV ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CS3 DIK DU5 E3Z EAD EAP EAS EBD EBLON EBS EMB EMK EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IGS IHR INH INR ITC KQ8 M1P M48 M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PQQKQ PROAC PSQYO PUEGO RBZ RNS ROL RPM RSV SMD SOJ SV3 TR2 TUS UKHRP W2D WOQ WOW XSB AAYXX ALIPV CITATION -A0 3V. ACRMQ ADINQ C24 CGR CUY CVF ECM EIF NPM PMFND 7TK 7XB 8FK AZQEC DWQXO K9. PKEHL PQEST PQUKI PRINS 7X8 1XC VOOES |
| ID | FETCH-LOGICAL-c586t-1c2ea8478f9f267d3a84a6e5536a0d6c730d4a603c78d08fbe4f9eab99392e303 |
| IEDL.DBID | M48 |
| ISSN | 1471-2377 |
| IngestDate | Wed Aug 27 01:17:43 EDT 2025 Fri Sep 12 12:35:00 EDT 2025 Fri Sep 05 09:07:17 EDT 2025 Fri Jul 25 23:08:20 EDT 2025 Tue Jun 17 22:04:20 EDT 2025 Tue Jun 10 21:04:16 EDT 2025 Fri Jan 31 01:44:16 EST 2025 Tue Jul 01 00:37:44 EDT 2025 Thu Apr 24 22:53:08 EDT 2025 Sat Sep 06 07:22:31 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Cognitive outcomes Health-related quality of life Post-acute interventions Social & caregiver burden Patient-reported experience measures Patient-reported outcome measures NMDA receptor encephalitis Patientreported experience measures NMDA receptor encephalitis Health-related quality of life Patient-reported outcome measures Patientreported experience measures Cognitive outcomes Post-acute interventions Social & caregiver burden |
| Language | English |
| License | 2024. The Author(s). Distributed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0 |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c586t-1c2ea8478f9f267d3a84a6e5536a0d6c730d4a603c78d08fbe4f9eab99392e303 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 ObjectType-Undefined-3 |
| OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s12883-024-03842-6 |
| PMID | 39242986 |
| PQID | 3102479663 |
| PQPubID | 44772 |
| PageCount | 8 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_37168edecd8b40388127db9810558f85 hal_primary_oai_HAL_hal_04986624v1 proquest_miscellaneous_3101795690 proquest_journals_3102479663 gale_infotracmisc_A808334132 gale_infotracacademiconefile_A808334132 pubmed_primary_39242986 crossref_primary_10_1186_s12883_024_03842_6 crossref_citationtrail_10_1186_s12883_024_03842_6 springer_journals_10_1186_s12883_024_03842_6 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2024-09-06 |
| PublicationDateYYYYMMDD | 2024-09-06 |
| PublicationDate_xml | – month: 09 year: 2024 text: 2024-09-06 day: 06 |
| PublicationDecade | 2020 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationTitle | BMC neurology |
| PublicationTitleAbbrev | BMC Neurol |
| PublicationTitleAlternate | BMC Neurol |
| PublicationYear | 2024 |
| Publisher | BioMed Central BioMed Central Ltd BMC |
| Publisher_xml | – name: BioMed Central – name: BioMed Central Ltd – name: BMC |
| References | C Finke (3842_CR25) 2013; 74 F Bartels (3842_CR8) 2020; 88 M Guasp (3842_CR27) 2022; 21 C Bull (3842_CR57) 2019; 54 D Wechsler (3842_CR42) 1997 IM Kinchin (3842_CR39) 2010; 9 3842_CR40 J Thompson Burdine (3842_CR38) 2021; 55 S Hirose (3842_CR35) 2022; 269 J Brenner (3842_CR36) 2024; 11 3842_CR45 3842_CR46 3842_CR47 F Graus (3842_CR9) 2016; 15 3842_CR43 C Kingsley (3842_CR48) 2017; 17 J Dalmau (3842_CR6) 2008; 7 AK Yeshokumar (3842_CR31) 2017; 312 J Heine (3842_CR12) 2015; 309 3842_CR50 LJ Bach (3842_CR22) 2014; 35 M Herdman (3842_CR55) 2011; 20 Y Zhang (3842_CR59) 2021; 12 SL Dworkin (3842_CR60) 2012; 41 3842_CR58 C Finke (3842_CR20) 2012; 83 3842_CR53 MAAM De Bruijn (3842_CR32) 2018; 90 AK Troyer (3842_CR49) 2002; 57 J Dalmau (3842_CR1) 2019; 18 J Schubert (3842_CR4) 2019; 6 R Balu (3842_CR7) 2019; 92 S Hirose (3842_CR34) 2023; 14 YC Tanguturi (3842_CR3) 2019; 28 D Wechsler (3842_CR41) 2008 3842_CR61 MR Brier (3842_CR15) 2016; 263 S Tariq (3842_CR37) 2013; 4 LB Krupp (3842_CR51) 1989; 46 DJ Buysse (3842_CR52) 1989; 28 C Finke (3842_CR14) 2016; 79 J Heine (3842_CR17) 2016; 263 LA Diaz-Arias (3842_CR56) 2021; 8 AR Tomlinson (3842_CR30) 2020; 108 AS Zigmond (3842_CR54) 1983; 67 J Heine (3842_CR26) 2021; 90 RA Blum (3842_CR29) 2020; 108 MJ Titulaer (3842_CR16) 2013; 12 S Rekers (3842_CR44) 2023; 56 3842_CR5 MS Blattner (3842_CR33) 2019; 266 OR Phillips (3842_CR11) 2018; 89 GL McKeon (3842_CR21) 2016; 22 D Dubey (3842_CR2) 2018; 83 L Nguyen (3842_CR10) 2023; 16 J Dalmau (3842_CR18) 2011; 10 Q Huang (3842_CR19) 2020; 1727 S Tarantino (3842_CR23) 2021; 11 H Ariño (3842_CR24) 2020; 95 C Finke (3842_CR28) 2024; 11 M Peer (3842_CR13) 2017; 4 |
| References_xml | – ident: 3842_CR5 doi: 10.1016/S0513-5117(08)79015-X – ident: 3842_CR43 – volume: 15 start-page: 391 year: 2016 ident: 3842_CR9 publication-title: Lancet Neurol doi: 10.1016/S1474-4422(15)00401-9 – volume: 11 start-page: e200168 year: 2024 ident: 3842_CR36 publication-title: Neurol Neuroimmunol Neuroinflamm doi: 10.1212/NXI.0000000000200168 – volume: 28 start-page: 193 year: 1989 ident: 3842_CR52 publication-title: Psychiatry Res doi: 10.1016/0165-1781(89)90047-4 – ident: 3842_CR47 – volume: 54 start-page: 1023 year: 2019 ident: 3842_CR57 publication-title: Health Serv Res doi: 10.1111/1475-6773.13187 – volume: 22 start-page: 828 year: 2016 ident: 3842_CR21 publication-title: J Int Neuropsychol Soc doi: 10.1017/S1355617716000679 – volume-title: Wechsler Adult Intelligence Scale year: 2008 ident: 3842_CR41 – volume: 57 start-page: P19 year: 2002 ident: 3842_CR49 publication-title: Journals Gerontol Ser B: Psychol Sci Social Sci doi: 10.1093/geronb/57.1.P19 – volume: 1727 start-page: 146549 year: 2020 ident: 3842_CR19 publication-title: Brain Res doi: 10.1016/j.brainres.2019.146549 – volume: 16 start-page: 7 year: 2023 ident: 3842_CR10 publication-title: IJGM doi: 10.2147/IJGM.S397429 – volume: 56 start-page: 2033 year: 2023 ident: 3842_CR44 publication-title: Behav Res doi: 10.3758/s13428-023-02134-0 – volume: 4 start-page: 768 year: 2017 ident: 3842_CR13 publication-title: Lancet Psychiatry doi: 10.1016/S2215-0366(17)30330-9 – ident: 3842_CR53 doi: 10.1037/t00742-000 – volume: 35 start-page: 863 year: 2014 ident: 3842_CR22 publication-title: NRE doi: 10.3233/NRE-141176 – volume: 12 start-page: 157 year: 2013 ident: 3842_CR16 publication-title: Lancet Neurol doi: 10.1016/S1474-4422(12)70310-1 – volume: 41 start-page: 1319 year: 2012 ident: 3842_CR60 publication-title: Arch Sex Behav doi: 10.1007/s10508-012-0016-6 – volume: 21 start-page: 899 year: 2022 ident: 3842_CR27 publication-title: Lancet Neurol doi: 10.1016/S1474-4422(22)00299-X – ident: 3842_CR40 – ident: 3842_CR46 doi: 10.1016/j.jclinepi.2010.04.011 – volume: 20 start-page: 1727 year: 2011 ident: 3842_CR55 publication-title: Qual Life Res doi: 10.1007/s11136-011-9903-x – volume: 74 start-page: 284 year: 2013 ident: 3842_CR25 publication-title: Ann Neurol doi: 10.1002/ana.23932 – ident: 3842_CR61 – volume: 312 start-page: 8 year: 2017 ident: 3842_CR31 publication-title: J Neuroimmunol doi: 10.1016/j.jneuroim.2017.08.010 – volume: 89 start-page: 518 year: 2018 ident: 3842_CR11 publication-title: J Neurol Neurosurg Psychiatry doi: 10.1136/jnnp-2017-316822 – volume: 95 start-page: e671 year: 2020 ident: 3842_CR24 publication-title: Neurology doi: 10.1212/WNL.0000000000009987 – volume: 266 start-page: 1007 year: 2019 ident: 3842_CR33 publication-title: J Neurol doi: 10.1007/s00415-019-09230-2 – volume: 8 start-page: e1064 year: 2021 ident: 3842_CR56 publication-title: Neurol Neuroimmunol Neuroinflamm doi: 10.1212/NXI.0000000000001064 – volume: 108 start-page: 107088 year: 2020 ident: 3842_CR29 publication-title: Epilepsy Behav doi: 10.1016/j.yebeh.2020.107088 – volume: 12 start-page: 796965 year: 2021 ident: 3842_CR59 publication-title: Front Immunol doi: 10.3389/fimmu.2021.796965 – ident: 3842_CR58 – volume: 9 start-page: 52 year: 2010 ident: 3842_CR39 publication-title: Int J Qualitative Methods doi: 10.1177/160940691000900106 – volume: 28 start-page: 79 year: 2019 ident: 3842_CR3 publication-title: Child Adolesc Psychiatr Clin N Am doi: 10.1016/j.chc.2018.07.005 – ident: 3842_CR45 doi: 10.1007/s11065-017-9349-1 – volume: 88 start-page: 148 year: 2020 ident: 3842_CR8 publication-title: Ann Neurol doi: 10.1002/ana.25754 – volume: 14 start-page: 1170961 year: 2023 ident: 3842_CR34 publication-title: Front Neurol doi: 10.3389/fneur.2023.1170961 – volume: 108 start-page: 107066 year: 2020 ident: 3842_CR30 publication-title: Epilepsy Behav doi: 10.1016/j.yebeh.2020.107066 – volume: 79 start-page: 727 year: 2016 ident: 3842_CR14 publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2015.02.024 – volume: 67 start-page: 361 year: 1983 ident: 3842_CR54 publication-title: Acta Psychiatr Scand doi: 10.1111/j.1600-0447.1983.tb09716.x – volume: 7 start-page: 1091 year: 2008 ident: 3842_CR6 publication-title: Lancet Neurol doi: 10.1016/S1474-4422(08)70224-2 – volume: 55 start-page: 336 year: 2021 ident: 3842_CR38 publication-title: Med Educ doi: 10.1111/medu.14380 – volume: 11 start-page: e200189 year: 2024 ident: 3842_CR28 publication-title: Neurol Neuroimmunol Neuroinflamm doi: 10.1212/NXI.0000000000200189 – volume: 309 start-page: 68 year: 2015 ident: 3842_CR12 publication-title: Neuroscience doi: 10.1016/j.neuroscience.2015.05.037 – volume: 83 start-page: 195 year: 2012 ident: 3842_CR20 publication-title: J Neurol Neurosurg Psychiatry doi: 10.1136/jnnp-2011-300411 – volume: 11 start-page: 1387 year: 2021 ident: 3842_CR23 publication-title: Brain Sci doi: 10.3390/brainsci11111387 – volume: 17 start-page: 137 year: 2017 ident: 3842_CR48 publication-title: BJA Educ doi: 10.1093/bjaed/mkw060 – ident: 3842_CR50 doi: 10.31234/osf.io/8hmxu – volume: 263 start-page: 1083 year: 2016 ident: 3842_CR15 publication-title: J Neurol doi: 10.1007/s00415-016-8083-6 – volume: 18 start-page: 1045 year: 2019 ident: 3842_CR1 publication-title: Lancet Neurol doi: 10.1016/S1474-4422(19)30244-3 – volume: 263 start-page: 2395 year: 2016 ident: 3842_CR17 publication-title: J Neurol doi: 10.1007/s00415-016-8277-y – volume: 10 start-page: 63 year: 2011 ident: 3842_CR18 publication-title: Lancet Neurol doi: 10.1016/S1474-4422(10)70253-2 – volume: 90 start-page: 949 year: 2021 ident: 3842_CR26 publication-title: Ann Neurol doi: 10.1002/ana.26241 – volume: 83 start-page: 166 year: 2018 ident: 3842_CR2 publication-title: Ann Neurol doi: 10.1002/ana.25131 – volume: 90 start-page: e1997 year: 2018 ident: 3842_CR32 publication-title: Neurology doi: 10.1212/WNL.0000000000005605 – volume: 92 start-page: e244 year: 2019 ident: 3842_CR7 publication-title: Neurology doi: 10.1212/WNL.0000000000006783 – volume: 6 start-page: e514 year: 2019 ident: 3842_CR4 publication-title: Neurol Neuroimmunol Neuroinflamm doi: 10.1212/NXI.0000000000000514 – volume: 269 start-page: 2486 year: 2022 ident: 3842_CR35 publication-title: J Neurol doi: 10.1007/s00415-021-10828-8 – volume-title: WMS-III Administration and Scoring Manual year: 1997 ident: 3842_CR42 – volume: 4 start-page: 204253331347919 year: 2013 ident: 3842_CR37 publication-title: JRSM Short Rep doi: 10.1177/2042533313479197 – volume: 46 start-page: 1121 year: 1989 ident: 3842_CR51 publication-title: Arch Neurol doi: 10.1001/archneur.1989.00520460115022 |
| SSID | ssj0017841 |
| Score | 2.3904006 |
| Snippet | Background
N-methyl-D-aspartate-receptor (NMDAR) encephalitis is a rare neurological autoimmune disease with severe neuropsychiatric symptoms during the acute... N-methyl-D-aspartate-receptor (NMDAR) encephalitis is a rare neurological autoimmune disease with severe neuropsychiatric symptoms during the acute phase.... Background N-methyl-D-aspartate-receptor (NMDAR) encephalitis is a rare neurological autoimmune disease with severe neuropsychiatric symptoms during the acute... BackgroundN-methyl-D-aspartate-receptor (NMDAR) encephalitis is a rare neurological autoimmune disease with severe neuropsychiatric symptoms during the acute... Abstract Background N-methyl-D-aspartate-receptor (NMDAR) encephalitis is a rare neurological autoimmune disease with severe neuropsychiatric symptoms during... |
| SourceID | doaj hal proquest gale pubmed crossref springer |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 322 |
| SubjectTerms | Adult Anti-N-Methyl-D-Aspartate Receptor Encephalitis - complications Anti-N-Methyl-D-Aspartate Receptor Encephalitis - psychology Autoimmune diseases Caregivers Cognitive outcomes Cognitive science Cohort Studies Complications and side effects Consciousness Encephalitis Europe - epidemiology Executive function Fatigue Female Focus groups Glutamate receptors Health-related quality of life Humans Interviews Long-term effects Male Medicine Medicine & Public Health Memory Mental disorders Mental illness N-Methyl-D-aspartic acid receptors Neurochemistry Neurology Neuropsychological Tests Neuropsychology Neuroscience Neurosurgery NMDA receptor encephalitis Patient outcomes Patient Reported Outcome Measures Patient-reported experience measures Patients Post-acute interventions Prospective Studies Quality of life Quality of Life - psychology Questionnaires Rare diseases Recovery of function Risk factors Study Protocol Subacute care Surveys Well being |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3LbtQwFLWgC8QG8SZQkEFILMBq4iSOswyPaoQoQoJK3VlJbLeVRsmImWHDhn_gD_kSznUeMKqADbvEcTwe39e5sX3M2FOftUXivBcpgpmAl3SiaRSyFK9SYpiDg6QNzkfv1eI4e3uSn_x21BetCRvogYeBO0gB6LWzrrW6yYi6JJGFbUpNBztqrwN7aVzGUzI1zh_QbNq0RUarg3VCh-oKxCOBJjIp1E4YCmz9s0--fEZLIi_izQtzpSEEHV5n10bsyKuhzzfYJdfdZFeOxtnxW-xrNdNs8t7zZd-dCvK8fNhqNXwe5_12Ay1za37ecbhRB0ktxWtRw7XQvLzj8IFuhVSck9Gvzgion6_5j2_fOcAi_1h9CJ-leCCm5cTz0EOZbrPjwzefXi3EeLiCaHOtNiJppasRmrQvvVSFTXFTK5fnqapjq1pYvkVBnLaFtrH2jct86eoGeKaUDnK8w_a6vnP3GC_qLLallVkNLNk0uGxSm6V1ossWtVXEkmmsTTsyj9MBGEsTMhCtzCAfA_mYIB-Dd57P76wG3o2_1n5JIpxrEmd2KIAmmVGTzL80KWLPSAEMWTa619bjBgX8SeLIMpUGXKWgLyO2v1MTFtnuPH4C2ex0ZlG9M1SGfEwrJbMvCdqYNMyMbmNtgLVlViADTSP2eH5MzdNSuM7121AHTjRXZRyxu4Nmzj8F0QBfaIzHi0lVfzX-5-G7_z-G7wG7KoOBEavFPtvbfN66hwBsm-ZRsM2f7jY2rQ priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELZokRAXxJtAQQYhcQCriZ04zgmFR7VCFCFBpb1Z8auttEqWZreXXvgP_EN-CTNONtWqorfdxHEcz8znb_yYIeR1yG2Z-RCYgMGMAUp6ZowELyVIgRHmACDxgPPhNzk7yr_Mi_k44daP2yo3mBiB2nUW58j3gYbwvARyLt4vfzHMGoWrq2MKjR1yMwMmgqkbyvnkcGW4prY5KKPkfp9hal0G9bBUqJwzuTUYxZj9EzLvnODGyKus88qKaRyIDu6SOyODpPUg8nvkhm_vk1uH4xr5A3JRT8E2aRfoomuPGeIvHQ5cDZPktFuv4Lt9T09bCmDqQV4L9ok1ADC4Ou8pIKFfgkNO0fSXJ0jXT3v69_cfCpSR_qi_x8kpGsPTUoz20IFKPSRHB59_fpyxMcUCs4WSK5ZZ7hsYoFSoApelE_Cnkb4ohGxSJy3Yv4MLqbClcqkKxueh8o0BVlNxD9J8RHbbrvVPCC2bPHWV43kDjNIY-GmEy0WTqcpCaZmQbNPX2o7xxzENxkJHP0RJPchHg3x0lI-GZ95OzyyH6BvXlv6AIpxKYuTseKE7O9ajIWoBDqLyzlunTI6hcDJeOlMpTBSqgioS8gYVQKN9Q_NsMx5TgI_ESFm6VkBacejnCdnbKgl2abduvwLZbDVmVn_VeA28MiUlz88zqGOjYXoEj15fqnpCXk63sXrcENf6bh3LAJQWskoT8njQzOlVIBpgGQr6491GVS8r_3_3Pb2-Lc_IbR5NB6NW7JHd1dnaPwdCtjIvotX9A0nJLwU priority: 102 providerName: ProQuest – databaseName: Springer Nature OA Free Journals dbid: C6C link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3ditQwFA7uCuKN-G91lSiCFxps0zRNL-voMogrgi7sXWiTdHdhaAdnxhtvfAff0CfxO22nOqwK3s2kJ5lOzn9PzxfGnjbK5UloGpHCmQlYySDqWiNLaXRKCHMwkNTgfPRez4_V25PsZITJoV6Y3-v3idEvVwkdhyvgSUScGiWF3mOXMxhekuaZnk0VA6qfbZti_jhvx_H0-PyTFd47o5cgL0aYF6qjvdM5vM6ujdEiLwf23mCXQnuTXTka6-G32NdyAtbkXcMXXXsqyNbyoblqeCDOu80achVW_LzlMJwBvFmI16KCMaFKfOCwemGJ5JuTmi_PKDQ_X_Ef375zhIf8Y_mhfxDFeyhaTsgOHcTnNjs-fPNpNhfjcQrCZUavReJkqOCMTFM0Uuc-xZdKhyxLdRV77aDrHgNx6nLjY9PUQTVFqGpEMIUM4Nwdtt92bbjHeF6p2BdeqgrRY13jY516lVaJKRyodcSS7V5bN2KN05EXC9vnHEbbgT8W_LE9fyzmPJ_mLAekjX9SvyIWTpSEkt0PQHjsqHQ2RTJogg_Om1oR7E0ic18Xhg4FNY3JIvaMBMCSLuP2XDW2JOBPEiqWLQ0CVHLzMmIHO5TQQbdz-Ql4s3Mz8_KdpTFkYEZrqb4kWGMrYXY0FCuL6FqqHDlnGrHH02Vanl5-a0O36WlgNjNdxBG7O0jm9FNgDSIKg_14sRXVX4v_ffvu_x_5A3ZV9qpEiBUHbH_9eRMeIhhb1496LfwJcXwn8A priority: 102 providerName: Springer Nature |
| Title | Assessment of long-term psychosocial outcomes in N-methyl-D-aspartate receptor encephalitis – the SAPIENCE study protocol |
| URI | https://link.springer.com/article/10.1186/s12883-024-03842-6 https://www.ncbi.nlm.nih.gov/pubmed/39242986 https://www.proquest.com/docview/3102479663 https://www.proquest.com/docview/3101795690 https://univ-lyon1.hal.science/hal-04986624 https://doaj.org/article/37168edecd8b40388127db9810558f85 |
| Volume | 24 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1bb9MwFLbWTUK8IO4ERmUQEg9gltiO7Twg1JVNFWLTBFTqm5WLs02qktILYv-ec5zLVG0g3hrHcVKfu4_9HULelDLXkStLJsCYMdCSjmWZgiilVAIR5kBB4gHnk1M1mcovs3i2Q7pyR-0Erm4N7bCe1HQ5__D759UnEPiPXuCNOlhFWDKXgbVhoTCSMzUgez5fhFv55HVWAXNs_rSRjhgXWneHaG4dY8tQeTz_XmsPLnDT5E2P9EY21Rup4_vkXutd0lHDDg_Ijqsekjsnbf78Ebka9UCctC7pvK7OGepm2hzGahbQab1ZAx-6Fb2sKChaB7Scs88sBeWDmXtHQUu6BQTrFNXC4gJd-csVZRScSfp9dOaXragHrqWIA1EDsz0m0-OjH-MJa4svsDw2as2inLsUTJcpk5IrXQi4SJWLY6HSsFA5aIYCGkKRa1OEpsycLBOXZuDvJNwBnZ-Q3aqu3DNCdSrDIim4TMHXzDL4mYlCijQySQ69VUCibqZt3iKTY4GMufURilG2oY4F6lhPHQvPvOufWTS4HP_sfYgE7HsiprZvqJfnthVRKyB0NK5weWEyiSA5EddFlhgsIWpKEwfkLZLfIi_C5-Vpe4AB_iRiaNmRAXcWnQIekP2tniCx-dbt10CZrY-ZjL5abIN4zSjF5a8Ixuj4y3ZSYcEX51JDhCoC8qq_jcPjVrnK1RvfB5RsrJIwIE8bvuxfBaQB_8PAfLzvGPV68L9P3_P_eNkLcpd76UFQi32yu15u3Evw19bZkAz0TA_J3uHR6dk3uBqr8dCvfQy9eP4B5jA4qA |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbtQwELbarQRcEP8sFDAIxIFaTZzEcQ4V2tJWW7q7qqCVejOJ7bSVVsmyPyDEhXfgfXgYnoQZ56daVfTW267jOLZn_M2M7Zkh5HUe6ti3ec4CEGYMUNKyLBNgpeQiwAhzAJDo4Dwcif5x-PEkOlkhfxpfGLxW2WCiA2pTatwj3wQ1hIcxKOfB-8lXhlmj8HS1SaGR1qkVzJYLMVY7dhzYH9_BhJtt7e8Avd9wvrd79KHP6iwDTEdSzJmvuU0Bo2We5FzEJoA_qbBRFIjUM0LDEjBQ4AU6lsaTeWbDPLFpBoI94RYGBO2ukrUQN1A6ZG17d3T4qT3HwFO9xlVHis2Zj8l9GYyEeYEMORNL4tBlDWhlw-oZXs28rPdeOrN1onDvDrld67C0VzHdXbJii3vkxrA-pb9PfvbacJ-0zOm4LE4ZSgBauXxV2_S0XMxh5u2MnhcU4NwCx4zZDksB4vB-gKWAxXYyL6cUwWdyhgbD-Yz-_fWbgtJKP_cO3fYYdQFyKcabKIGpH5Dja5n-h6RTlIV9TGichp5JDA9T0GmzDH5mgQmD1JeJhtqiS_xmrpWuI6BjIo6xcpaQFKqijwL6KEcfBe-8a9-ZVPE_rqy9jSRsa2LsbldQTk9VDQUqABNVWmO1kVmIwXh8HpsskZiqVOYy6pK3yAAKEQa6p9PaUQIGibG6VE-C2ozKB--S9aWagAx66fEroM1SZ_q9gcIysAulEDz85kMbDYepGr5m6mKxdcnL9jE2j1fyClsuXB0A80gkXpc8qjiz_RSQBvQcCfOx0bDqReP_n74nV_flBbnZPxoO1GB_dPCU3OJuGWEMjXXSmU8X9hmoh_Pseb0GKfly3cv-H5zxcnc |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELZoK1VcUHmHFjAIiQNYTWLHcY6BslqWtqpUKvVmJX60lVbJqpvlwoX_wD_klzCTF6wKSNx2nbGTeDyvjOczIa-8MGnkvGccjBkDLelYWUqIUrzkiDAHChILnI-O5fRMzM6T89-q-Nvd7kNKsqtpQJSmqtlfWN-JuJL7ywgPyWVgX1jIlYiZ3CBbKskyCL-28nx2OhszCZhXG4pl_thzzSC1uP2jdt64xM2RNz3PG1nT1hhNdsid3oukecf2u-SWq-6R7aM-T36ffM1HwE1aezqvqwuGOph2RVfdh3Jarxp4dbekVxUFheqAZ3N2wApQMpihdxS0oVtAUE5R_BeX6LJfLemPb98puI30ND9pP1DRFqKWIuJDDcvqATmbfPj8fsr6YxaYSZRsWGRiV4CRUj7zsUwthz-FdEnCZRFaaUAHWGgIuUmVDZUvnfCZK0rwbLLYAUcfks2qrtxjQtNChDazsSjAqyxL-FlyK3gRqcwAtQxINMy1Nj0GOR6FMddtLKKk7vijgT-65Y-GPm_GPosOgeOf1O-QhSMlome3DfX1he6FUXMIEpWzzlhVCoTDieLUlpnCw0KVV0lAXuMC0Cjj8Him6EsV4CURLUvnChxXNP9xQPbWKEE2zdrll8CbtYeZ5oca2yAyU1LG4ksEYwwrTPcKZKnB645FCrEoD8iL8TIOj5viKlevWhpQp4nMwoA86lbmeCtgDXgaCubj7bBUfw3-9-l78n_kz8n2ycFEH348_rRLbsetVCGoxR7ZbK5X7in4a035rBfJn-zMNJ0 |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Assessment+of+long-term+psychosocial+outcomes+in+N-methyl-D-aspartate+receptor+encephalitis+-+the+SAPIENCE+study+protocol&rft.jtitle=BMC+neurology&rft.au=Boeken%2C+Ole+Jonas&rft.au=Heine%2C+Josephine&rft.au=Duda-Sikula%2C+Marta&rft.au=Patricio%2C+V%C3%ADctor&rft.date=2024-09-06&rft.issn=1471-2377&rft.eissn=1471-2377&rft.volume=24&rft.issue=1&rft.spage=322&rft_id=info:doi/10.1186%2Fs12883-024-03842-6&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2377&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2377&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2377&client=summon |